Dystonia

• FDA approval · 2023-07-03
  FDA Approved: BENZTROPINE MESYLATE — Supplemental Application (Fresenius Kabi USA, LLC)

  The FDA approved a supplemental application for benztropine mesylate, submitted by Fresenius Kabi USA, LLC.

• FDA approval · 2021-10-14
  FDA Approved: BENZTROPINE MESYLATE — Original Application (Hikma Pharmaceuticals USA Inc.)

  FDA approved the original application for benztropine mesylate (generic) from Hikma Pharmaceuticals USA Inc., for use in treating Parkinsoni…

• FDA approval · 2014-02-25
  FDA Approved: BENZTROPINE MESYLATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

  FDA approved a supplemental application for benztropine mesylate from Hikma Pharmaceuticals USA Inc., indicating an approved change to an ex…

• FDA approval · 2009-07-28
  FDA Approved: BENZTROPINE MESYLATE — Original Application (Fresenius Kabi USA, LLC)

  FDA approved the original application for benztropine mesylate (generic) by Fresenius Kabi USA, LLC, expanding access to treatment for Parki…